Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds

Article excerpt

In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana, THC and CBD, had significantly less agitation than people who received a placebo.